Mp43-10 the Role of Surveillance Biopsy With No Cancer as a Prognostic Marker for Reclassification: Results From the Canary Prostate Active Surveillance Study (Pass)
Journal of Urology - Netherlands
doi 10.1016/j.juro.2017.02.1320
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2017
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)